Vanguard Personalized Indexing Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 66,567 shares of LXRX stock, worth $94,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,567
Previous 65,330
1.89%
Holding current value
$94,525
Previous $62,000
46.77%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LXRX
# of Institutions
134Shares Held
226MCall Options Held
2.5MPut Options Held
271K-
Artal Group S.A. Luxembourg, N4136MShares$193 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$55.3 Million2.06% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.52MShares$13.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.83MShares$5.44 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $268M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...